IMF TV

From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF-TV is your all-access ticket to critical myeloma research, patient education and guidance. Check back often for regularly updated content. 

Jun
20
How does a myeloma patient’s lifestyle impact overall health?
In this video, Dr. Brian G.M. Durie explains which lifestyle choices can improve myeloma patients’ outcomes.
Jun
20
The Importance of Bone Heath and Treatment Updates
/sites/default/files/pdfs/LWM/lwm_bonehealth_rajefaiman.pdf Join us on June 20, 2018 for a free Living Well with Myeloma teleconference about "The Importance of Bone Health and Treatment Updates."(...)
Jun
14
Stockholm 2018: The Role of CRISPR Gene Editing
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about the role of CRISPR gene-editing in the landscape of multiple myeloma treatment with Dr. Joseph Mikhael (IMF Chief(...)
Jun
14
How does minimal residual disease (MRD) testing affect treatment decisions?
In this video, Dr. Brian G.M. Durie explains why MRD-negative status and MRD-positive status are not clear indicators for next steps in a myeloma patient’s treatment.
Jun
14
Stockholm 2018: What is the Role of Mass Spectrometry in Multiple Myeloma
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about mass spectrometry with Dr. Joseph Mikhael (IMF Chief Medical Officer) and Dr. Sagar Lonial (Emory University, Atlanta(...)
Jun
14
Stockholm 2018: Status of MRD Testing
​In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about the status of minimal residual (MRD) testing with Dr. Joseph Mikhael (IMF Chief Medical Officer) and Dr. Sagar Lonial(...)